Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad Reza Shalbafan

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Human Psychopharmacology|May 10, 2017
L-carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double-blind studySomaye Arabzadeh, Maryam Shahhossenie, Bita Mesgarpour, et al.
Medical Journal of the Islamic Republic of Iran|February 22, 2019
Raphe nuclei echogenicity changes in obsessive-compulsive disorderNahid Mohammadzade, Mohammad Reza Shalbafan, Seyed Vahid Shariat, et al.
Psychiatry and Clinical Neurosciences|August 5, 2016
Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trialSophia Esalatmanesh, Zoha Abrishami, Atefeh Zeinoddini, et al.
Psychiatry Research|February 11, 2018
L-carnosine as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trialAlireza Ghajar, Mohammad-Reza Khoaie-Ardakani, Zahara Shahmoradi, et al.
Journal of Affective Disorders|February 28, 2018
Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trialMaryam Ghazizadeh-Hashemi, Alireza Ghajar, Mohammad-Reza Shalbafan, et al.
Journal of Psychiatric Research|May 29, 2018
Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trialMona Khalaj, Amene Saghazadeh, Elham Shirazi, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Human Psychopharmacology|May 10, 2017
L-carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double-blind studySomaye Arabzadeh, Maryam Shahhossenie, Bita Mesgarpour, et al.
Medical Journal of the Islamic Republic of Iran|February 22, 2019
Raphe nuclei echogenicity changes in obsessive-compulsive disorderNahid Mohammadzade, Mohammad Reza Shalbafan, Seyed Vahid Shariat, et al.
Psychiatry and Clinical Neurosciences|August 5, 2016
Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trialSophia Esalatmanesh, Zoha Abrishami, Atefeh Zeinoddini, et al.
Psychiatry Research|February 11, 2018
L-carnosine as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trialAlireza Ghajar, Mohammad-Reza Khoaie-Ardakani, Zahara Shahmoradi, et al.
Journal of Affective Disorders|February 28, 2018
Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trialMaryam Ghazizadeh-Hashemi, Alireza Ghajar, Mohammad-Reza Shalbafan, et al.
Journal of Psychiatric Research|May 29, 2018
Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trialMona Khalaj, Amene Saghazadeh, Elham Shirazi, et al.
Pageof 1